Lumina Pharmaceuticals Inc. — Form D
Lumina Pharmaceuticals Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-20. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-06-20
- Form: D
- Accession: 0002069952-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2025-05-07
- Revenue range: Decline to Disclose
- SEC file number: 021-549406
Issuer
- Name: Lumina Pharmaceuticals Inc.
- CIK: 0002069952
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 1 HUNTINGTON AVE. #1802, BOSTON, MA, 02116
- Phone: 617-420-1150
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Peter Gregory Caravan | Director | Boston, MA |
| Cara Gregory Ferreira | Director | Boston, MA |
| Alma Gregory Sorensen | Director | Boston, MA |
| Cara Gregory Ferreira | Executive Officer | Boston, MA |
| Alma Gregory Sorensen | Executive Officer | Boston, MA |
More